KLYG (Kelyniam Global) Effective Interest Rate on Debt %: 0.00% (As of Mar. 2008)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Kelyniam Global Effective Interest Rate on Debt %?

Kelyniam Global KLYG -1.52% Effective Interest Rate on Debt % is 0.00% as of Mar. 2008.

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Kelyniam Global's annualized positive value of Interest Expense for the quarter that ended in Mar. 2008 was $0.00 Mil. Kelyniam Global's average total debt for the quarter that ended in Mar. 2008 was $0.05 Mil. Therefore, Kelyniam Global's annualized Effective Interest Rate on Debt % for the quarter that ended in Mar. 2008 was 0.00%.

Kelyniam Global  (OTCPK:KLYG) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.

Kelyniam Global Effective Interest Rate on Debt % Related Terms

Kelyniam Global Effective Interest Rate on Debt % Historical Data

* Premium members only.

The historical data trend for Kelyniam Global's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kelyniam Global Effective Interest Rate on Debt % Chart

Kelyniam Global Annual Data
Trend Dec06 Dec07
Effective Interest Rate on Debt %
0.00 0.00

Kelyniam Global Quarterly Data
Dec06 Mar07 Jun07 Sep07 Dec07 Mar08
Effective Interest Rate on Debt % Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

KLYG vs VASO, WCUI, MODD: Effective Interest Rate on Debt % Comparison

For the Medical Devices subindustry, Kelyniam Global's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kelyniam Global Effective Interest Rate on Debt % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Kelyniam Global's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Kelyniam Global's Effective Interest Rate on Debt % falls into.


Kelyniam Global Effective Interest Rate on Debt % Calculation

Kelyniam Global's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Dec. 2007 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (A: Dec. 2006 )+Total Debt  (A: Dec. 2007 ))/ count )
=-1  *  0/( (0.073+0.054)/ 2 )
=-1  *  0/0.0635
=0.00 %

where

Total Debt  (A: Dec. 2006 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=0.031 + 0.042
=0.073

Total Debt  (A: Dec. 2007 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=0.023 + 0.031
=0.054

Kelyniam Global's annualized Effective Interest Rate on Debt % for the quarter that ended in Mar. 2008 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (Q: Dec. 2007 )+Total Debt  (Q: Mar. 2008 ))/ count )
=-1  *  0/( (0.054+0.049)/ 2 )
=-1  *  0/0.0515
=0.00 %

where

Total Debt  (Q: Dec. 2007 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=0.023 + 0.031
=0.054

Total Debt  (Q: Mar. 2008 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=0.021 + 0.028
=0.049

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is four times the quarterly (Mar. 2008) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.

What does a Effective Interest Rate on Debt % of 0.00% mean?
Kelyniam Global (KLYG) has a Effective Interest Rate on Debt % of 0.00% as of Mar. 2008. Effective interest rate on debt is the rate a company actually pays on its debt. View historical data on Kelyniam Global and its competitors.
Is Kelyniam Global's Effective Interest Rate on Debt % too high?
Kelyniam Global's current Effective Interest Rate on Debt % is 0.00%.
How does Kelyniam Global's Effective Interest Rate on Debt % compare to VASO and WCUI?
Kelyniam Global's Effective Interest Rate on Debt % of 0.00% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Effective Interest Rate on Debt % for a Medical Devices & Instruments company?
A good Effective Interest Rate on Debt % depends on the Medical Devices & Instruments industry context. However, Effective Interest Rate on Debt % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Effective Interest Rate on Debt % mean?
A high Effective Interest Rate on Debt % can signal that a stock is expensive relative to its fundamentals. Effective interest rate on debt is the rate a company actually pays on its debt. View historical data on Kelyniam Global and its competitors. Kelyniam Global's current Effective Interest Rate on Debt % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kelyniam Global stock overvalued right now?
Kelyniam Global (KLYG) has a current Effective Interest Rate on Debt % of 0.00%. The current Effective Interest Rate on Debt % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Effective Interest Rate on Debt % calculated?
Effective Interest Rate on Debt % is calculated from a company's financial statements. For Kelyniam Global (KLYG), the current Effective Interest Rate on Debt % is 0.00% as of Mar. 2008. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kelyniam Global Business Description

Address 97 River Road, Suite A, Canton, CT, USA, 06019
Kelyniam Global Inc specializes in the rapid production of custom prosthetic cranial implants utilizing computer-aided design and computer aided manufacturing of developed medical grade polymers. The Company develops, manufactures, and distributes custom cranial and maxilla-facial implants for patients requiring the reconstruction of cranial and certain facial structures. The Company's business operations consist of regulatory approvals, manufacturing operations and distribution to customers and markets in the United States.